These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 21868738)

  • 21. Influence of the site of arterial occlusion on multiple baseline hemodynamic MRI parameters and post-thrombolytic recanalization in acute stroke.
    Derex L; Hermier M; Adeleine P; Pialat JB; Wiart M; Berthezène Y; Froment JC; Trouillas P; Nighoghossian N
    Neuroradiology; 2004 Nov; 46(11):883-7. PubMed ID: 15517229
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Importance of cerebral artery recanalization in patients with stroke with and without neurological improvement after intravenous thrombolysis.
    Kharitonova TV; Melo TP; Andersen G; Egido JA; Castillo J; Wahlgren N;
    Stroke; 2013 Sep; 44(9):2513-8. PubMed ID: 23881960
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Early recanalization rate of major occluded brain arteries after intravenous tissue plasminogen activator therapy using serial magnetic resonance angiography studies.
    Kimura K; Iguchi Y; Shibazaki K; Aoki J; Uemura J
    Eur Neurol; 2009; 62(5):287-92. PubMed ID: 19713704
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Brush sign on 3-T T2*-weighted MRI as a potential predictor of hemorrhagic transformation after tissue plasminogen activator therapy.
    Terasawa Y; Yamamoto N; Morigaki R; Fujita K; Izumi Y; Satomi J; Harada M; Nagahiro S; Kaji R
    Stroke; 2014 Jan; 45(1):274-6. PubMed ID: 24172577
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Clinical and MRI scale to predict very poor outcome in tissue plasminogen activator patients.
    Kimura K; Sakamoto Y; Iguchi Y; Shibazaki K
    Eur Neurol; 2011; 65(5):291-5. PubMed ID: 21508643
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The susceptibility vessel sign at the proximal M1: a strong predictor for poor outcome after intravenous thrombolysis.
    Aoki J; Kimura K; Shibazaki K; Saji N; Uemura J; Sakamoto Y; Nagai K
    J Neurol Sci; 2015 Jan; 348(1-2):195-200. PubMed ID: 25529923
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Safety and efficacy of intravenous tissue plasminogen activator stroke treatment in the 3- to 6-hour window using multimodal transcranial Doppler/MRI selection protocol.
    Ribo M; Molina CA; Rovira A; Quintana M; Delgado P; Montaner J; Grivé E; Arenillas JF; Alvarez-Sabín J
    Stroke; 2005 Mar; 36(3):602-6. PubMed ID: 15692107
    [TBL] [Abstract][Full Text] [Related]  

  • 28. New appearance of extraischemic microbleeds on T2*-weighted magnetic resonance imaging 24 hours after tissue-type plasminogen activator administration.
    Kimura K; Aoki J; Shibazaki K; Saji N; Uemura J; Sakamoto Y
    Stroke; 2013 Oct; 44(10):2776-81. PubMed ID: 23887835
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Factors associated with proximal carotid axis occlusion in patients with acute stroke and atrial fibrillation.
    Sakamoto Y; Sato S; Kuronuma Y; Nagatsuka K; Minematsu K; Toyoda K
    J Stroke Cerebrovasc Dis; 2014; 23(5):799-804. PubMed ID: 24103668
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Diagnostic and prognostic value of early MR Imaging vessel signs in hyperacute stroke patients imaged <3 hours and treated with recombinant tissue plasminogen activator.
    Schellinger PD; Chalela JA; Kang DW; Latour LL; Warach S
    AJNR Am J Neuroradiol; 2005 Mar; 26(3):618-24. PubMed ID: 15764589
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Prognostic significance of blood pressure variability after thrombolysis in acute stroke.
    Delgado-Mederos R; Ribo M; Rovira A; Rubiera M; Munuera J; Santamarina E; Delgado P; Maisterra O; Alvarez-Sabin J; Molina CA
    Neurology; 2008 Aug; 71(8):552-8. PubMed ID: 18550860
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Location of the Susceptibility Vessel Sign on T2*-Weighted MRI and Early Recanalization within 1 Hour after Tissue Plasminogen Activator Administration.
    Aoki J; Kimura K; Shibazaki K; Sakamoto Y; Saji N; Uemura J
    Cerebrovasc Dis Extra; 2013; 3(1):111-20. PubMed ID: 24163686
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Association of pretreatment ASPECTS scores with tPA-induced arterial recanalization in acute middle cerebral artery occlusion.
    Tsivgoulis G; Saqqur M; Sharma VK; Lao AY; Hoover SL; Alexandrov AV;
    J Neuroimaging; 2008 Jan; 18(1):56-61. PubMed ID: 18190497
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Treatment with tPA predicts better outcome even if MCA occlusion persists.
    Kablau M; Alonso A; Hennerici MG; Fatar M
    Int J Stroke; 2013 Oct; 8(7):496-502. PubMed ID: 22340025
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A simple clinical and MRI scale to predict good outcome in t-PA patients.
    Kimura K; Sakamoto Y; Iguchi Y; Shibazaki K; Watanabe M; Aoki J; Inoue T; Uemura J
    Neurol Res; 2011 Dec; 33(10):1038-43. PubMed ID: 22196756
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Time-Dependent Thrombus Resolution After Tissue-Type Plasminogen Activator in Patients With Stroke and Mice.
    Kim YD; Nam HS; Kim SH; Kim EY; Song D; Kwon I; Yang SH; Lee K; Yoo J; Lee HS; Heo JH
    Stroke; 2015 Jul; 46(7):1877-82. PubMed ID: 25967573
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Recanalization within one hour after intravenous tissue plasminogen activator is associated with favorable outcome in acute stroke patients.
    Kimura K; Iguchi Y; Shibazaki K; Aoki J; Watanabe M; Kobayashi K; Sakamoto Y
    Eur Neurol; 2010; 63(6):331-6. PubMed ID: 20516694
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Recanalization of the MCA should play an important role in dramatic recovery after t-PA therapy in patients with ICA occlusion.
    Kimura K; Iguchi Y; Shibazaki K; Iwanaga T; Aoki J
    J Neurol Sci; 2009 Oct; 285(1-2):130-3. PubMed ID: 19573877
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Circadian rhythms in the efficacy of intravenous alteplase in patients with acute ischemic stroke and middle cerebral artery occlusion.
    Vilas D; Gomis M; Blanco M; Cortés J; Millán M; Pérez de la Ossa N; Dorado L; López-Cancio E; Suñol A; Dávalos A
    Chronobiol Int; 2012 Dec; 29(10):1383-9. PubMed ID: 23130962
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Risk factors of symptomatic intracerebral hemorrhage after tPA therapy for acute stroke.
    Lansberg MG; Thijs VN; Bammer R; Kemp S; Wijman CA; Marks MP; Albers GW;
    Stroke; 2007 Aug; 38(8):2275-8. PubMed ID: 17569874
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.